Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-02-26 @ 12:20 AM
Study NCT ID:
NCT03910660
Status:
COMPLETED
Last Update Posted:
2025-10-20
First Post:
2019-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
Sponsor:
BioXcel Therapeutics Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-04
First Submit QC Date:
None
Study First Post Date:
2019-04-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-17
Last Update Post Date:
2025-10-20
Last Update Post Date Type:
ESTIMATED